Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07729995
What this trial is testing

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erthematosus (SLE)Dermatomyositis (DM)+1 more
Luminary Therapeutics 94
Not applicableNot Yet RecruitingNCT07785739
What this trial is testing

Clinical Prediction Model for Disease Progression in Primary Membranous Nephropathy

Who this might be right for
Membranous NephropathyNephrotic SyndromeKidney Diseases
Assiut University 128
Large-scale testing (Phase 3)UnknownNCT05432531
What this trial is testing

Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 60
Large-scale testing (Phase 3)Active Not RecruitingNCT05852938
What this trial is testing

Zigakibart in Adults With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 383
Not applicableLooking for participantsNCT07823478
What this trial is testing

HEALTH Home Urinalysis Testing

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 160
Testing effectiveness (Phase 2)UnknownNCT02160132
What this trial is testing

A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.

Who this might be right for
Glomerulonephritis, IGAPeripapillary CrescentNecrosis+1 more
Sun Yat-sen University 180
Very early researchLooking for participantsNCT07507201
What this trial is testing

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus Erthematosus (SLE)Multi-Drug Resistant Nephrotic Syndrome+3 more
The Children's Hospital of Zhejiang University School of Medicine 15
Large-scale testing (Phase 3)Looking for participantsNCT06341205
What this trial is testing

Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

Who this might be right for
Membranous Nephropathy
Centre Hospitalier Universitaire de Nice 120
Testing effectiveness (Phase 2)Looking for participantsNCT05538208
What this trial is testing

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

Who this might be right for
Lupus Nephritis
Children's Hospital Medical Center, Cincinnati 105
Very early researchLooking for participantsNCT06497361
What this trial is testing

Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease

Who this might be right for
Lupus NephritisIgG4-related Disease
Tongji Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06350110
What this trial is testing

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisAutoimmune Diseases+6 more
Essen Biotech 75
Post-approval studies (Phase 4)Looking for participantsNCT07604311
What this trial is testing

Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Nanfang Hospital, Southern Medical University 288
Not applicableStudy completedNCT03723512
What this trial is testing

Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study

Who this might be right for
C3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative Glomerulonephritis+2 more
Mario Negri Institute for Pharmacological Research 7
Not applicableWithdrawnNCT01093781
What this trial is testing

Aliskiren in Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07659704
What this trial is testing

CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of Sao Paulo 16
Not applicableNot Yet RecruitingNCT07481084
What this trial is testing

IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data Collection

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 80
Post-approval studies (Phase 4)Ended earlyNCT02226341
What this trial is testing

ACTHar in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Columbia University 8
Large-scale testing (Phase 3)Study completedNCT05534919
What this trial is testing

Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301

Who this might be right for
Primary Immunoglobulin a Nephropathy (IgAN)
Everest Medicines (Singapore) Pte. Ltd. 21
Early research (Phase 1)Study completedNCT01221181
What this trial is testing

Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy

Who this might be right for
Dense Deposit DiseaseMembranoproliferative Glomerulonephritis
Columbia University 6
Next Page